Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: Comparison of etiology, risk factors and outcome

Journal of Chemotherapy

Volumn 10, Issue 3, 1998, Pages 236-242

  Krupova, I ^c,e,g   Kaiserova, E ^a   Foltinova, A ^a   Kovacicova, G ^d   Kiskova, M ^d   Krchnakova, A ^c   Kunova, A ^b   Trupl, J ^b   West, D ^f   Krcmery Jr , V ^c,d,g  

^a National Cancer Center   (Slovakia)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

^c ST ELIZABETH CANCER INSTITUTE   (Slovakia)

^d TRNAVA UNIVERSITY   (Slovakia)

^e Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^f UNIVERSITY OF SCRANTON   (United States)

^g Heydukova 10   (Slovakia)

Author keywords

Bacteremia; Fungemia; Leukemia; Quinolones

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; CYTOTOXIC AGENT; FLUCONAZOLE; GENTAMICIN; IMIPENEM; NEOMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CANCER CENTER; CANCER PATIENT; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FUNGEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA; TREATMENT OUTCOME;

EID: 15444352818     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.3.236     Document Type: Article

References (22)

1. EORTC Annual Report of the Invasive Fungal Infections Cooperative Group 1996. EORTC, Brussels, 1996, 35 pp.
2. EORTC International Antimicrobial Therapy Cooperation Group. Reduction of fever and steptococcal bacteremia in granulocytopenic patients with cancer. JAMA 1994; 272,10: 1183-1189.
3. Viscoli C, Garavent I, Castagnola D. Infection prevention in children with acute leukemia. Med Rev 1993; 52, 51: 33-38.
4. Cruciani D, Viscoli C, Garaventa J. Norfloxacin vs ciprofloxacin in prevention of fever in neutropenic children. J Chemother 1993; 6,2: 112-115.
5. Cap J, Kaiserová E, Soltes L, et al. Fluconazol plus ciprofloxacin in infection prevention of neutropenic children. Chemotherapy 1993; 40, 2: 121-126.
6. Danisovicova A, Hruskovic I, Kaiserova E, et al. Nuclear magnetic resonance imaging in children receiving quinolones: No evidence of quinolone associated artropathy. Drugs 1996; 81, 52: 133-134.
7. EORTC International Antimicrobial Therapy Cooperation Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978; 137: 14-29.
8. Zinner SH, Gaya D. Glauser MP, Klastersky J, Schimpff SC, Tattersall MH. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. J Clin Oncol 1983; 1: 597-603.
9. Klastersky J, Glauser MP, Schimpff SC, Zinner SH, Gaya H. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremia in cancer patients with granulocytopenia. Antimicrob Agents Cemother 1986; 29: 263-270.
10. EORTC International Antimicrobial Therapy Cooperation Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692-1698.
11. Muis N, Kamps WA, Dantert J. Prevention of infection in children with acute leukemia. Supp Care Cancer 1996; 4: 200-206.
12. Domanski M, Boguslawska-Javorska I. Changes in microbiological pattern infections in children with malignancies within 10 years in one institute. 3rd Symposium on Febrile Neutropenia. Brussels 1995, Abstr. N. 20.
13. Schaison L. Treatment of febrile neutropenia in leukemic children. 3rd Symposium on Febrile Neutropenia. Brussels 1995, Abstr. N. 4.
14. Guiot MFL, Lord LJA, Vossen JMJJ. Prevalence of PEN-resistant viridans streptococci in healthy children and in children with malignant haematologic disorders. Clin Infect Dis 1994; 13: 645-650.
15. Aguino VM, Pappo A, Buchavan GK, Tkaczewski I, Mustafa MM. The changing epidemiology of bacteremia in neutropenic children in cancer. Pediatr Infect Dis 1995; 14: 140-143
16. Krcmery V Jr, Spanik S, Trupl J, et al. Breakthrough bacteremia during ofloxacin prophylaxis in patients receiving ofloxacin. J Chemother 1997; 8,3: 189-193.
17. Kunova A, Trupl J, Pichna P, et al. Candida glabrata, C. krusei and other non-albicans Candida spp. yeasts in 1989-1993 in a single cancer institution. Chemotherapy 1995; 41,2: 84-95.
18. Demitrovicova A, Spanik S, Pichna P, et al. Bacteremia in patients with various malignancies: any association between neoplastic regimen and etiology? Antiinfect Drugs Chemother 1997; 12, 2: 163-171.
19. Spanik S, Mrazova M, Kukuckova E, et al. Catheter associated bacteremia in cancer patients. Appl Adv Microbiol J 1997; 6,1: 41-52.
20. Hughes W and the IDSA Ad Hoc Working Group. Guidelines for empiric therapy of febrile granulocytopenic patients. Clin Infect Dis 1997; 22,7: 1133-1150.
21. Krcmery V Jr, Trupl J. Viridans streptococcal bacteremia due to penicillin resistant streptococci. Lancet 1995; 326,12: 1102-1103.
22. Krcmery V Jr, Trupl J, Spanik S, et al. Resistance pathogens of 2883 isolates from a single cancer institution. A 7-year experience. Acta Oncol 1997; 53,3: 169-180.